↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

37 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Bevacizumab   Bevacizumab   D06409   1件: VEGFA   3件: Pathways in cancer, Renal cell carcinoma, VEGF signaling pathway   9件:
13,
34,
85,
86,
87,
89,
227,
280,
331 
 2   Bortezomib   Bortezomib   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331 
 3   Cetuximab   Cetuximab   D03455   1件: EGFR   3件: ErbB signaling pathway, MAPK signaling pathway, Pathways in cancer   5件:
34,
51,
86,
89,
331 
 4   Chimeric murine human anti-il-6 monoclonal antibody   -   -   -   -   1件:
331 
 5   Cnto 328   -   -   -   -   1件:
331 
 6   Cnto328   -   -   -   -   1件:
331 
 7   Cx-4945 oral formulation   -   -   -   -   1件:
331 
 8   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 9   Dexamethason   -   -   -   -   3件:
13,
46,
331 
 10   Doxorubicin   Doxorubicin   D03899   -   -   5件:
26,
28,
34,
61,
331 
 11   Doxorubicin hydrochloride   Doxorubicin   D03899   -   -   4件:
26,
34,
61,
331 
 12   Etoposide   Etoposide   D00125, D04107   -   -   11件:
11,
13,
14,
26,
28,
34,
60,
65,
85,
164,
331 
 13   Filgrastim   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   25件:
2,
6,
13,
25,
26,
28,
34,
35,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
96,
113,
164,
283,
284,
285,
331 
 14   Filgrastim (g-csf)   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
331 
 15   G-csf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   12件:
6,
13,
16,
49,
51,
60,
65,
85,
96,
284,
285,
331 
 16   Hyaluronidase   Hyaluronidase   D04455, D04456, D06604   -   -   3件:
28,
65,
331 
 17   Interferon-alpha   -   -   -   -   1件:
331 
 18   Liposomal doxorubicin   Doxorubicin   D03899   -   -   1件:
331 
 19   Methotrexate   Methotrexate   D00142, D02115   2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331 
 20   Nelfinavir   Nelfinavir   D00899, D08259   -   -   3件:
49,
265,
331 
 21   Pomalidomide   Pomalidomide   D08976   2件: IL6, TNF   6件: Apoptosis, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, TNF signaling pathway   6件:
28,
34,
51,
85,
227,
331 
 22   Prednisone   Ethanol   D00068, D02798, D04855, D06542   -   -   43件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331 
 23   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 24   Rituximab or rituximab hyaluronidase human   Hyaluronidase, Rituximab   D02994, D04455, D04456, D06604   1件: MS4A1   1件: Hematopoietic cell lineage   1件:
331 
 25   Siltuximab   Siltuximab   D09669   1件: IL6   2件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway   2件:
28,
331 
 26   Sirolimus   Sirolimus   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 27   Suramin   Suramin   -   -   -   1件:
331 
 28   Temsirolimus   Temsirolimus   D06068   1件: MTOR   3件: ErbB signaling pathway, Pathways in cancer, mTOR signaling pathway   4件:
13,
34,
89,
331 
 29   Thalidomide   Thalidomide   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   18件:
2,
16,
20,
28,
49,
51,
53,
65,
84,
85,
94,
96,
97,
227,
271,
280,
298,
331 
 30   Thalidomide, cyclophosphamide and prednisone   Cyclophosphamide, Ethanol, Thalidomide   D00068, D00287, D00754, D02798, D04855, D06542, D07760   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   1件:
331 
 31   Tocilizumab   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   16件:
2,
13,
40,
41,
43,
46,
50,
51,
53,
54,
55,
86,
107,
266,
271,
331 
 32   Tocilizumab [roactemra/actemra]   Tocilizumab   D02596   1件: IL6R   3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway   2件:
46,
331 
 33   Valganciclovir   Valganciclovir   D02495   -   -   6件:
28,
60,
85,
97,
299,
331 
 34   Valganciclovir (vgc)   Valganciclovir   D02495   -   -   1件:
331 
 35   Valproic acid   Valproic Acid   D00399   6件: ABAT, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2   2件: Calcium signaling pathway, GABAergic synapse   10件:
3,
5,
26,
34,
65,
89,
90,
222,
256,
331 
 36   Vincristine   Vincristine   D02197, D08679   9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8   1件: Gap junction   4件:
26,
34,
61,
331 
 37   Zidovudine   Zidovudine   D00413   -   -   6件:
25,
26,
135,
265,
325,
331 

先頭へ